.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Boehringer Ingelheim
Fish and Richardson
Daiichi Sankyo
Novartis
AstraZeneca
Dow
Express Scripts
Baxter
Colorcon

Generated: July 20, 2017

DrugPatentWatch Database Preview

ROSIGLITAZONE MALEATE AND GLIMEPIRIDE Drug Profile

« Back to Dashboard

Which patents cover Rosiglitazone Maleate And Glimepiride, and when can generic versions of Rosiglitazone Maleate And Glimepiride launch?

Rosiglitazone Maleate And Glimepiride is a drug marketed by Teva Pharms Usa and is included in one NDA.

The generic ingredient in ROSIGLITAZONE MALEATE AND GLIMEPIRIDE is glimepiride; rosiglitazone maleate. There are fourteen drug master file entries for this compound. Additional details are available on the glimepiride; rosiglitazone maleate profile page.

Summary for Tradename: ROSIGLITAZONE MALEATE AND GLIMEPIRIDE

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list104,794
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ROSIGLITAZONE MALEATE AND GLIMEPIRIDE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa
ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
glimepiride; rosiglitazone maleate
TABLET;ORAL078709-001Apr 1, 2016RXNoYes► Subscribe► Subscribe
Teva Pharms Usa
ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
glimepiride; rosiglitazone maleate
TABLET;ORAL078709-003Apr 1, 2016RXNoNo► Subscribe► Subscribe
Teva Pharms Usa
ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
glimepiride; rosiglitazone maleate
TABLET;ORAL078709-002Apr 1, 2016RXNoNo► Subscribe► Subscribe
Teva Pharms Usa
ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
glimepiride; rosiglitazone maleate
TABLET;ORAL078709-004Apr 1, 2016RXNoNo► Subscribe► Subscribe
Teva Pharms Usa
ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
glimepiride; rosiglitazone maleate
TABLET;ORAL078709-005Apr 1, 2016RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Merck
Harvard Business School
Federal Trade Commission
US Department of Justice
Farmers Insurance
Medtronic
Daiichi Sankyo
Express Scripts
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot